JPRN-UMIN000048780招募中未知
ovel diagnostic markers to evaluate gut dysbiosis in patients with sepsis - Novel diagnostic markers to evaluate gut dysbiosis in patients with sepsis
Chiba University Hospital Emergency and Critical Care Medicine 1-8-1 Inohana, Chuo, Chiba 260-8677, Japan0 个研究点目标入组 100 人开始时间: 2022年8月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with inflammatory bowel disease Patients with diarrhea prior to ICU admission Patients who have received multiple antimicrobial agents for a long period of time prior to ICU admission Patients who are judged by the principal investigator to be inappropriate as study subjects
研究者
相似试验
尚未招募
3 期
sing probiotics to reduce the side effects and toxicities caused by chemoradiation treatment in patients of esophageal, colon, rectal and anal canal cancer.CTRI/2024/03/064552Indian Council of Medical Research
已完成
不适用
Study on analysis of gut bacteria and their by products from stool samplesCTRI/2022/02/040469For BugWorks Research India Pvt Ltd Leucine Rich Bio Pvt Ltd
已完成
不适用
ovel diagnostic markers for necrotising enterocolitis in the premature infantnecrotising enterocolitis10017969NL-OMON34937niversitair Medisch Centrum Groningen40
招募中
不适用
Enterobacterial analysis as the biomarker for the inflammatory bowel diseaseJPRN-UMIN000034001Juntendo Universuty30
尚未招募
不适用
To study the gut flora after traumatic brain injury.CTRI/2020/01/022731All India Institute of Medical Sciences AIIMS New Delhi